Microsporidiosis epidemiology and demographics
|
Microsporidiosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Microsporidiosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Microsporidiosis epidemiology and demographics |
|
Risk calculators and risk factors for Microsporidiosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ogheneochuko Ajari, MB.BS, MS [2];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [3]
Overview
The overall prevalence is not accurately estimated especially in the whole population (because microsporidosis is usually investigated in immunocompromised patients with correlateing GI symptoms to microsporidosis). The disease is present allover the world. In HIV patients with diarrhea, the prevalence of microsporidosis was 39% being the most common isolated organism.
Epidemiology and Demographics
Prevalence:
- The overall prevalence is not accurately estimated especially in the whole population (because microsporidosis is usually investigated in immunocompromised patients with correlateing GI symptoms to microsporidosis).[1][2]
- In HIV patients with diarrhea, the prevalence of microsporidosis was 39% being the most common isolated organism.
Case fatality rate:
- The case-fatality rate of intestinal microsporidiosis is approximately 56% among HIV patients.
Race
- There is no racial predilection to the microsporidosis.[3]
Age
- Patients of all age groups may develop microspordosis.[3]
Sex
- Males and females are affected equally by microsporidosis.[3]
Geographic distribution
- Microsporidiosis infections occur worldwide with no geographic prediliction.[2]
References
- ↑ Kotler DP, Orenstein JM (1994). "Prevalence of intestinal microsporidiosis in HIV-infected individuals referred for gastroenterological evaluation". Am. J. Gastroenterol. 89 (11): 1998–2002. PMID 7942725.
- ↑ 2.0 2.1 "CDC - DPDx - Microsporidiosis".
- ↑ 3.0 3.1 3.2 Didier ES, Weiss LM (2006). "Microsporidiosis: current status". Curr Opin Infect Dis. 19 (5): 485–92. doi:10.1097/01.qco.0000244055.46382.23. PMC 3109650. PMID 16940873.